
Impact of COVID-19 pandemic on endoscopic retrograde cholangiopancreatography; a single center experience
Author(s) -
Mohammed Tag-Adeen,
Mohammad S. Yousef,
Heba Ahmed Osman,
Muhammad Abdel-Gawad,
Mohamed Elsayed,
Eisuke Ozawa,
Ahlam Sapra
Publication year - 2021
Publication title -
revista española de enfermedades digestivas/revista española de enfermedades digestivas
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.331
H-Index - 38
eISSN - 2340-4167
pISSN - 1130-0108
DOI - 10.17235/reed.2021.8229/2021
Subject(s) - medicine , endoscopic retrograde cholangiopancreatography , covid-19 , complication , pandemic , alkaline phosphatase , bilirubin , surgery , gastroenterology , pancreatitis , biochemistry , chemistry , disease , infectious disease (medical specialty) , enzyme
the COVID-19 pandemic has impacted on several aspects of health care services worldwide. The aim of the study was to determine its influence on the case volume, success rate and complication rate of endoscopic retrograde cholangiopancreatography (ERCP).